Boehringer Ingelheim Pharmaceuticals, Inc. (United States)

Boehringer Ingelheim is a family-owned global pharmaceutical company developing breakthrough therapies in respiratory diseases, metabolic diseases, cardiovascular conditions, and oncology. Key products include Spiriva (tiotropium) and Ofev (nintedanib) for lung diseases, Jardiance (empagliflozin) for type 2 diabetes and heart failure, and Pradaxa (dabigatran) for stroke prevention. Boehringer Ingelheim’s research-driven approach creates medicines that improve human and animal health.